Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Teresa R. Lang
Observed names:
Teresa Lang,
Teresa R Lang
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5030122281
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
2019
·
Dalene M. Bott-Kitslaar
, Robert D. McBane
, et al.
·
Mayo Clinic Proceedings
·
43
Influence of Primary Cancer Site on Clinical Outcomes of Anticoagulation for Associated Venous Thromboembolism
2022
·
Waldemar E. Wysokinski
, Damon E. Houghton
, et al.
·
Thrombosis Research
·
18
Calf Vein Thrombosis Outcomes Comparing Anticoagulation and Serial Ultrasound Imaging Management Strategies
2021
·
Wiktoria Kuczmik
, Waldemar E. Wysokinski
, et al.
·
Mayo Clinic Proceedings
·
17
Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
2025
·
Danielle T. Vlazny
, Robert D. McBane
, et al.
·
Research and Practice in Thrombosis and Haemostasis
·
5
PDF
Extended Full Dose Versus Low Dose Direct Oral Anticoagulants in Cancer and Overweight Patients
2023
·
Danielle T. Vlazny
, Azza Ahmed
, et al.
·
Blood
·
3
Bleeding in Patients with Genitourinary Cancer compared to Non-Genitourinary Cancer Treated with Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
2024
·
Teresa Lang
·
2
Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin
2018
·
Damon E. Houghton
, Dalene M. Bott-Kitslaar
, et al.
·
Blood
·
2
Case Study of Warfarin Anticoagulation and Unexpected Results
2024
·
Teresa Lang
Show more works
View as search
Works count:
8
Citation count:
90
H-index:
4
I10-index:
3
Year
Topic
Type
